PDE4A and asthma: As a significant increase in PDE4 activity has been reported in patients with asthma or allergy compared with healthy individuals [12,13], it is therefore of interest to explore PDE4 inhibition as a potential therapeutic option for treatment of atopic asthma, given the proposed anti-inflammatory mode of action [14].